Intracranial myxoid angiomatoid fibrous histiocytoma with “classic” histology and EWSR1:CREM fusion providing insight for reconciliation with intracranial myxoid mesenchymal tumors
Angiomatoid fibrous histiocytoma (AFH) is an uncommon soft tissue neoplasm that can exhibit diverse morphological features, including myxoid change. Rarely, the tumor occurs intracranially and poses considerable diagnostic challenges to neuropathologists. This is compounded by a recently coined enti...
Gespeichert in:
Veröffentlicht in: | Neuropathology 2021-08, Vol.41 (4), p.306-314 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 314 |
---|---|
container_issue | 4 |
container_start_page | 306 |
container_title | Neuropathology |
container_volume | 41 |
creator | Tan, Nicholas J.H. Pratiseyo, Patricia Diana Wahjoepramono, Eka J. Kuick, Chik Hong Goh, Jian Yuan Chang, Kenneth T.E. Tan, Char Loo |
description | Angiomatoid fibrous histiocytoma (AFH) is an uncommon soft tissue neoplasm that can exhibit diverse morphological features, including myxoid change. Rarely, the tumor occurs intracranially and poses considerable diagnostic challenges to neuropathologists. This is compounded by a recently coined entity, referred to as intracranial myxoid mesenchymal tumor (IMMT). These tumors show significant overlaps with intracranial myxoid AFH from clinicopathological and molecular genetic viewpoints. We described an unusual intracranial tumor in a 30‐year‐old man. The tumor exhibited “classic” histological features of myxoid AFH and EWSR1:CREM fusion, a relatively novel variant of EWSR1:CREB family fusion, first identified in IMMT. We also performed a comprehensive literature review comparing the clinicopathological features of intracranial AFHs and IMMTs. Peritumoral lymphoplasmacytic cuffing appears to be the only morphological finding that is consistently absent in reported cases of IMMT while being present in most intracranial AFHs. Otherwise, both tumors showed considerable overlaps in clinical, histological, and immunohistochemical features and have a common molecular genetic signature of EWSR1:CREB family fusion, including EWSR1:CREM fusion. Our case appeared to be the first described EWSR1:CREM‐fused intracranial tumor to show prominent peritumoral lymphoplasmacytic cuffing and myxoid change in addition to most of the other “classic” morphologic features of AFH. As such, while the current literature appears to be lacking when it comes to defining intracranial myxoid AFH and IMMT as separate nosological entities, they likely represent a morphological spectrum of a common entity characterized by EWSR1 rearrangement, akin to solitary fibrous tumors and hemangiopericytomas with the signal transducer and activator of transcription 6 gene (STAT6) rearrangement. |
doi_str_mv | 10.1111/neup.12737 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2557250714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2557250714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3487-4f9c9e659e54d2a1a8860e0dead160c6ad35213a78ecf2490d1d808c97bb97ec3</originalsourceid><addsrcrecordid>eNp9kU9u3CAUh1HVqJkm2fQAFVJ3lZyAjY3prhpN2khpUuWPsrQYwDMvsmECuIl3OUh7j54nJykzk3ZVhQ2I9_Hxnn4IvaPkkKZ1ZM2wOqQ5L_grNKGMkYzyWrxGEyKoyKqSsV30NoRbQigXef0G7RYsL1lRiQn6fWKjl8pLC7LD_fjgQGNpF-B6GdfnFubeDQEvIURwaoypgO8hLvHT40_VyRBAPT3-2tRd5xZjeq3x7Obygn6aXsy-4XYI4CxeefcDNNgFBhtgsYy4dR57o5xV0IGMa2jjhf901JtgrFqOfbqKQ-982Ec7reyCOXje99D18exq-jU7Pf9yMv18mqmC1TxjrVDCVKUwJdO5pLKuK2KINlLTiqhK6qLMaSF5bVSbM0E01TWpleDzueBGFXvow9abBrgbTIjNrRu8TV82eVnyvCScskR93FLKuxC8aZuVh176saGkWYfUrENqNiEl-P2zcpj3Rv9D_6aSALoF7qEz4wuq5mx2_X0r_QN-HKSL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2557250714</pqid></control><display><type>article</type><title>Intracranial myxoid angiomatoid fibrous histiocytoma with “classic” histology and EWSR1:CREM fusion providing insight for reconciliation with intracranial myxoid mesenchymal tumors</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Tan, Nicholas J.H. ; Pratiseyo, Patricia Diana ; Wahjoepramono, Eka J. ; Kuick, Chik Hong ; Goh, Jian Yuan ; Chang, Kenneth T.E. ; Tan, Char Loo</creator><creatorcontrib>Tan, Nicholas J.H. ; Pratiseyo, Patricia Diana ; Wahjoepramono, Eka J. ; Kuick, Chik Hong ; Goh, Jian Yuan ; Chang, Kenneth T.E. ; Tan, Char Loo</creatorcontrib><description>Angiomatoid fibrous histiocytoma (AFH) is an uncommon soft tissue neoplasm that can exhibit diverse morphological features, including myxoid change. Rarely, the tumor occurs intracranially and poses considerable diagnostic challenges to neuropathologists. This is compounded by a recently coined entity, referred to as intracranial myxoid mesenchymal tumor (IMMT). These tumors show significant overlaps with intracranial myxoid AFH from clinicopathological and molecular genetic viewpoints. We described an unusual intracranial tumor in a 30‐year‐old man. The tumor exhibited “classic” histological features of myxoid AFH and EWSR1:CREM fusion, a relatively novel variant of EWSR1:CREB family fusion, first identified in IMMT. We also performed a comprehensive literature review comparing the clinicopathological features of intracranial AFHs and IMMTs. Peritumoral lymphoplasmacytic cuffing appears to be the only morphological finding that is consistently absent in reported cases of IMMT while being present in most intracranial AFHs. Otherwise, both tumors showed considerable overlaps in clinical, histological, and immunohistochemical features and have a common molecular genetic signature of EWSR1:CREB family fusion, including EWSR1:CREM fusion. Our case appeared to be the first described EWSR1:CREM‐fused intracranial tumor to show prominent peritumoral lymphoplasmacytic cuffing and myxoid change in addition to most of the other “classic” morphologic features of AFH. As such, while the current literature appears to be lacking when it comes to defining intracranial myxoid AFH and IMMT as separate nosological entities, they likely represent a morphological spectrum of a common entity characterized by EWSR1 rearrangement, akin to solitary fibrous tumors and hemangiopericytomas with the signal transducer and activator of transcription 6 gene (STAT6) rearrangement.</description><identifier>ISSN: 0919-6544</identifier><identifier>EISSN: 1440-1789</identifier><identifier>DOI: 10.1111/neup.12737</identifier><identifier>PMID: 34254369</identifier><language>eng</language><publisher>Melbourne: John Wiley & Sons Australia, Ltd</publisher><subject>Adult ; angiomatoid fibrous histiocytoma ; Brain cancer ; Brain Neoplasms - genetics ; CREM ; Cyclic AMP Response Element Modulator - genetics ; Cyclic AMP response element-binding protein ; EWSR1 ; FLI-1 protein ; Gene Fusion ; Gene rearrangement ; Histiocytoma ; Histiocytoma, Benign Fibrous ; Histiocytoma, Malignant Fibrous ; Humans ; intracranial myxoid mesenchymal tumor ; Literature reviews ; Male ; Mesenchyme ; Morphology ; myxoid AFH ; Neoplasia ; RNA-Binding Protein EWS - genetics ; Soft Tissue Neoplasms ; Stat6 protein ; Transcription ; Tumors</subject><ispartof>Neuropathology, 2021-08, Vol.41 (4), p.306-314</ispartof><rights>2021 Japanese Society of Neuropathology.</rights><rights>2021 Japanese Society of Neuropathology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3487-4f9c9e659e54d2a1a8860e0dead160c6ad35213a78ecf2490d1d808c97bb97ec3</citedby><cites>FETCH-LOGICAL-c3487-4f9c9e659e54d2a1a8860e0dead160c6ad35213a78ecf2490d1d808c97bb97ec3</cites><orcidid>0000-0001-7163-3233 ; 0000-0002-1470-3175</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fneup.12737$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fneup.12737$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34254369$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tan, Nicholas J.H.</creatorcontrib><creatorcontrib>Pratiseyo, Patricia Diana</creatorcontrib><creatorcontrib>Wahjoepramono, Eka J.</creatorcontrib><creatorcontrib>Kuick, Chik Hong</creatorcontrib><creatorcontrib>Goh, Jian Yuan</creatorcontrib><creatorcontrib>Chang, Kenneth T.E.</creatorcontrib><creatorcontrib>Tan, Char Loo</creatorcontrib><title>Intracranial myxoid angiomatoid fibrous histiocytoma with “classic” histology and EWSR1:CREM fusion providing insight for reconciliation with intracranial myxoid mesenchymal tumors</title><title>Neuropathology</title><addtitle>Neuropathology</addtitle><description>Angiomatoid fibrous histiocytoma (AFH) is an uncommon soft tissue neoplasm that can exhibit diverse morphological features, including myxoid change. Rarely, the tumor occurs intracranially and poses considerable diagnostic challenges to neuropathologists. This is compounded by a recently coined entity, referred to as intracranial myxoid mesenchymal tumor (IMMT). These tumors show significant overlaps with intracranial myxoid AFH from clinicopathological and molecular genetic viewpoints. We described an unusual intracranial tumor in a 30‐year‐old man. The tumor exhibited “classic” histological features of myxoid AFH and EWSR1:CREM fusion, a relatively novel variant of EWSR1:CREB family fusion, first identified in IMMT. We also performed a comprehensive literature review comparing the clinicopathological features of intracranial AFHs and IMMTs. Peritumoral lymphoplasmacytic cuffing appears to be the only morphological finding that is consistently absent in reported cases of IMMT while being present in most intracranial AFHs. Otherwise, both tumors showed considerable overlaps in clinical, histological, and immunohistochemical features and have a common molecular genetic signature of EWSR1:CREB family fusion, including EWSR1:CREM fusion. Our case appeared to be the first described EWSR1:CREM‐fused intracranial tumor to show prominent peritumoral lymphoplasmacytic cuffing and myxoid change in addition to most of the other “classic” morphologic features of AFH. As such, while the current literature appears to be lacking when it comes to defining intracranial myxoid AFH and IMMT as separate nosological entities, they likely represent a morphological spectrum of a common entity characterized by EWSR1 rearrangement, akin to solitary fibrous tumors and hemangiopericytomas with the signal transducer and activator of transcription 6 gene (STAT6) rearrangement.</description><subject>Adult</subject><subject>angiomatoid fibrous histiocytoma</subject><subject>Brain cancer</subject><subject>Brain Neoplasms - genetics</subject><subject>CREM</subject><subject>Cyclic AMP Response Element Modulator - genetics</subject><subject>Cyclic AMP response element-binding protein</subject><subject>EWSR1</subject><subject>FLI-1 protein</subject><subject>Gene Fusion</subject><subject>Gene rearrangement</subject><subject>Histiocytoma</subject><subject>Histiocytoma, Benign Fibrous</subject><subject>Histiocytoma, Malignant Fibrous</subject><subject>Humans</subject><subject>intracranial myxoid mesenchymal tumor</subject><subject>Literature reviews</subject><subject>Male</subject><subject>Mesenchyme</subject><subject>Morphology</subject><subject>myxoid AFH</subject><subject>Neoplasia</subject><subject>RNA-Binding Protein EWS - genetics</subject><subject>Soft Tissue Neoplasms</subject><subject>Stat6 protein</subject><subject>Transcription</subject><subject>Tumors</subject><issn>0919-6544</issn><issn>1440-1789</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9u3CAUh1HVqJkm2fQAFVJ3lZyAjY3prhpN2khpUuWPsrQYwDMvsmECuIl3OUh7j54nJykzk3ZVhQ2I9_Hxnn4IvaPkkKZ1ZM2wOqQ5L_grNKGMkYzyWrxGEyKoyKqSsV30NoRbQigXef0G7RYsL1lRiQn6fWKjl8pLC7LD_fjgQGNpF-B6GdfnFubeDQEvIURwaoypgO8hLvHT40_VyRBAPT3-2tRd5xZjeq3x7Obygn6aXsy-4XYI4CxeefcDNNgFBhtgsYy4dR57o5xV0IGMa2jjhf901JtgrFqOfbqKQ-982Ec7reyCOXje99D18exq-jU7Pf9yMv18mqmC1TxjrVDCVKUwJdO5pLKuK2KINlLTiqhK6qLMaSF5bVSbM0E01TWpleDzueBGFXvow9abBrgbTIjNrRu8TV82eVnyvCScskR93FLKuxC8aZuVh176saGkWYfUrENqNiEl-P2zcpj3Rv9D_6aSALoF7qEz4wuq5mx2_X0r_QN-HKSL</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Tan, Nicholas J.H.</creator><creator>Pratiseyo, Patricia Diana</creator><creator>Wahjoepramono, Eka J.</creator><creator>Kuick, Chik Hong</creator><creator>Goh, Jian Yuan</creator><creator>Chang, Kenneth T.E.</creator><creator>Tan, Char Loo</creator><general>John Wiley & Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><orcidid>https://orcid.org/0000-0001-7163-3233</orcidid><orcidid>https://orcid.org/0000-0002-1470-3175</orcidid></search><sort><creationdate>202108</creationdate><title>Intracranial myxoid angiomatoid fibrous histiocytoma with “classic” histology and EWSR1:CREM fusion providing insight for reconciliation with intracranial myxoid mesenchymal tumors</title><author>Tan, Nicholas J.H. ; Pratiseyo, Patricia Diana ; Wahjoepramono, Eka J. ; Kuick, Chik Hong ; Goh, Jian Yuan ; Chang, Kenneth T.E. ; Tan, Char Loo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3487-4f9c9e659e54d2a1a8860e0dead160c6ad35213a78ecf2490d1d808c97bb97ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>angiomatoid fibrous histiocytoma</topic><topic>Brain cancer</topic><topic>Brain Neoplasms - genetics</topic><topic>CREM</topic><topic>Cyclic AMP Response Element Modulator - genetics</topic><topic>Cyclic AMP response element-binding protein</topic><topic>EWSR1</topic><topic>FLI-1 protein</topic><topic>Gene Fusion</topic><topic>Gene rearrangement</topic><topic>Histiocytoma</topic><topic>Histiocytoma, Benign Fibrous</topic><topic>Histiocytoma, Malignant Fibrous</topic><topic>Humans</topic><topic>intracranial myxoid mesenchymal tumor</topic><topic>Literature reviews</topic><topic>Male</topic><topic>Mesenchyme</topic><topic>Morphology</topic><topic>myxoid AFH</topic><topic>Neoplasia</topic><topic>RNA-Binding Protein EWS - genetics</topic><topic>Soft Tissue Neoplasms</topic><topic>Stat6 protein</topic><topic>Transcription</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tan, Nicholas J.H.</creatorcontrib><creatorcontrib>Pratiseyo, Patricia Diana</creatorcontrib><creatorcontrib>Wahjoepramono, Eka J.</creatorcontrib><creatorcontrib>Kuick, Chik Hong</creatorcontrib><creatorcontrib>Goh, Jian Yuan</creatorcontrib><creatorcontrib>Chang, Kenneth T.E.</creatorcontrib><creatorcontrib>Tan, Char Loo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Neuropathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tan, Nicholas J.H.</au><au>Pratiseyo, Patricia Diana</au><au>Wahjoepramono, Eka J.</au><au>Kuick, Chik Hong</au><au>Goh, Jian Yuan</au><au>Chang, Kenneth T.E.</au><au>Tan, Char Loo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intracranial myxoid angiomatoid fibrous histiocytoma with “classic” histology and EWSR1:CREM fusion providing insight for reconciliation with intracranial myxoid mesenchymal tumors</atitle><jtitle>Neuropathology</jtitle><addtitle>Neuropathology</addtitle><date>2021-08</date><risdate>2021</risdate><volume>41</volume><issue>4</issue><spage>306</spage><epage>314</epage><pages>306-314</pages><issn>0919-6544</issn><eissn>1440-1789</eissn><abstract>Angiomatoid fibrous histiocytoma (AFH) is an uncommon soft tissue neoplasm that can exhibit diverse morphological features, including myxoid change. Rarely, the tumor occurs intracranially and poses considerable diagnostic challenges to neuropathologists. This is compounded by a recently coined entity, referred to as intracranial myxoid mesenchymal tumor (IMMT). These tumors show significant overlaps with intracranial myxoid AFH from clinicopathological and molecular genetic viewpoints. We described an unusual intracranial tumor in a 30‐year‐old man. The tumor exhibited “classic” histological features of myxoid AFH and EWSR1:CREM fusion, a relatively novel variant of EWSR1:CREB family fusion, first identified in IMMT. We also performed a comprehensive literature review comparing the clinicopathological features of intracranial AFHs and IMMTs. Peritumoral lymphoplasmacytic cuffing appears to be the only morphological finding that is consistently absent in reported cases of IMMT while being present in most intracranial AFHs. Otherwise, both tumors showed considerable overlaps in clinical, histological, and immunohistochemical features and have a common molecular genetic signature of EWSR1:CREB family fusion, including EWSR1:CREM fusion. Our case appeared to be the first described EWSR1:CREM‐fused intracranial tumor to show prominent peritumoral lymphoplasmacytic cuffing and myxoid change in addition to most of the other “classic” morphologic features of AFH. As such, while the current literature appears to be lacking when it comes to defining intracranial myxoid AFH and IMMT as separate nosological entities, they likely represent a morphological spectrum of a common entity characterized by EWSR1 rearrangement, akin to solitary fibrous tumors and hemangiopericytomas with the signal transducer and activator of transcription 6 gene (STAT6) rearrangement.</abstract><cop>Melbourne</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>34254369</pmid><doi>10.1111/neup.12737</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-7163-3233</orcidid><orcidid>https://orcid.org/0000-0002-1470-3175</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0919-6544 |
ispartof | Neuropathology, 2021-08, Vol.41 (4), p.306-314 |
issn | 0919-6544 1440-1789 |
language | eng |
recordid | cdi_proquest_journals_2557250714 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adult angiomatoid fibrous histiocytoma Brain cancer Brain Neoplasms - genetics CREM Cyclic AMP Response Element Modulator - genetics Cyclic AMP response element-binding protein EWSR1 FLI-1 protein Gene Fusion Gene rearrangement Histiocytoma Histiocytoma, Benign Fibrous Histiocytoma, Malignant Fibrous Humans intracranial myxoid mesenchymal tumor Literature reviews Male Mesenchyme Morphology myxoid AFH Neoplasia RNA-Binding Protein EWS - genetics Soft Tissue Neoplasms Stat6 protein Transcription Tumors |
title | Intracranial myxoid angiomatoid fibrous histiocytoma with “classic” histology and EWSR1:CREM fusion providing insight for reconciliation with intracranial myxoid mesenchymal tumors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T01%3A46%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intracranial%20myxoid%20angiomatoid%20fibrous%20histiocytoma%20with%20%E2%80%9Cclassic%E2%80%9D%20histology%20and%20EWSR1:CREM%20fusion%20providing%20insight%20for%20reconciliation%20with%20intracranial%20myxoid%20mesenchymal%20tumors&rft.jtitle=Neuropathology&rft.au=Tan,%20Nicholas%20J.H.&rft.date=2021-08&rft.volume=41&rft.issue=4&rft.spage=306&rft.epage=314&rft.pages=306-314&rft.issn=0919-6544&rft.eissn=1440-1789&rft_id=info:doi/10.1111/neup.12737&rft_dat=%3Cproquest_cross%3E2557250714%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2557250714&rft_id=info:pmid/34254369&rfr_iscdi=true |